![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 22, 16450-16458, June 2, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute of Experimental Cardiology, Cardiology Research
Center, Moscow 121552, Russia
Urokinase plasminogen activator (uPA) is thought
to exert its effects on cell growth, adhesion, and migration by
mechanisms involving proteolysis and interaction with its cell surface
receptor (uPAR). The functional properties of uPA and the significance of its various domains for chemotactic activity were analyzed using
human airway smooth muscle cells (hAWSMC). The wild-type uPA (r-uPAwt),
inactive urokinase with single mutation (His204 to Gln)
(r-uPAH/Q), urokinase with mutation of His204
to Gln together with a deletion of growth factor-like domain (r-uPAH/Q-GFD), the catalytic domain of urokinase
(r-uPALMW), and its kringle domain (r-KD) were expressed in
Escherichia coli. We demonstrate that glycosylated uPA,
r-uPAwt, r-uPAH/Q, and r-uPAH/Q-GFD elicited
similar chemotactic effects. Half-maximal chemotaxis (EC50)
were apparent at approximately 2 nM with all the uPA
variants. The kringle domain induced cell migration with an
EC50 of about 6 nM, whereas the denaturated
r-KD and r-uPALMW were without effect. R-uPAwt-induced
chemotaxis was dependent on an association with uPAR and a uPA-kringle
domain-binding site, determined using a monoclonal uPAR antibody to
prevent the uPA-uPAR interaction, and a monoclonal antibody to the
uPA-kringle domain. The binding of iodinated r-uPAwt with hAWSMC was
due to interaction with a high affinity binding site on the uPAR, and a
lower affinity binding site on an unidentified cell surface
target, which was mediated exclusively through the kringle domain of
urokinase. Specific binding of r-uPAH/Q-GFD to hAWSMC
involved an interaction with a single site whose characteristics were
similar to those of the low affinity site of r-uPAwt binding to hAWSMC.
uPAR-deficient HEK 293 cells specifically bound r-uPAwt and
r-uPAH/Q-GFD via a single, similar type of binding site.
These cells migrated when stimulated by r-uPAH/Q-GFD and
uPAwt, but not r-uPALMW. HEK 293 cells transfected with the
uPAR cDNA expressed two classes of sites that bound r-uPAwt;
however, only a single site was responsible for the binding of
r-uPAH/Q-GFD. Together, these findings indicate that
uPA-induced chemotaxis is dependent on the binding of the
uPA-kringle to the membrane surface of cells and the association of uPA
with uPAR.
The Chemotactic Action of Urokinase on Smooth Muscle Cells Is
Dependent on Its Kringle Domain
CHARACTERIZATION OF INTERACTIONS AND CONTRIBUTION TO
CHEMOTAXIS*
,
*
This work was supported by Russian Fundamental Research
Foundation Grants 96-04-50714 and 00-04-48699.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Partial fulfilment of a PhD degree.
§
To whom correspondence should be addressed: Molecular Endocrinology
Laboratory, Inst. of Experimental Cardiology, Cardiology Research
Center, Cherepkovskaya St., 15, Moscow 121552, Russia. Tel.:
7-095-414-67-13; Fax: 7-095-414-67-12; E-mail:
V.Stepanova@cardio.ru.
This article has been cited by other articles:
![]() |
V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M. S. Marks, Y. Parfyonova, et al. Nuclear translocation of urokinase-type plasminogen activator Blood, July 1, 2008; 112(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirakawa, Y. Karashima, M. Watanabe, C. Kimura, Y. Ito, and M. Oike Protein Kinase A Inhibits Lysophosphatidic Acid-Induced Migration of Airway Smooth Muscle Cells J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1102 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Govindaraju, M.-C. Michoud, M. Al-Chalabi, P. Ferraro, W. S. Powell, and J. G. Martin Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration Am J Physiol Cell Physiol, November 1, 2006; 291(5): C957 - C965. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Wang, K. Bdeir, S. Yarovoi, D. B. Cines, W. Fang, and E. Abraham Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury J. Immunol., October 15, 2006; 177(8): 5550 - 5557. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest, September 1, 2006; 130(3): 741 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Franco, I. Vocca, M. V. Carriero, D. Alfano, L. Cito, I. Longanesi-Cattani, P. Grieco, L. Ossowski, and M. P. Stoppelli Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and {alpha}v{beta}5 integrin J. Cell Sci., August 15, 2006; 119(16): 3424 - 3434. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Ustach and H.-R. C. Kim Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells Mol. Cell. Biol., July 15, 2005; 25(14): 6279 - 6288. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Jeffery Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bernstein, R. S. Greenberg, L. Taliana, and S. K. Masur Urokinase Anchors uPAR to the Actin Cytoskeleton Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2967 - 2977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Puig-de-Morales, E. Millet, B. Fabry, D. Navajas, N. Wang, J. P. Butler, and J. J. Fredberg Cytoskeletal mechanics in adherent human airway smooth muscle cells: probe specificity and scaling of protein-protein dynamics Am J Physiol Cell Physiol, September 1, 2004; 287(3): C643 - C654. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, X. Cai, J. M. Lopez-Guisa, S. J. Collins, and A. A. Eddy Mitogenic Signaling of Urokinase Receptor-Deficient Kidney Fibroblasts: Actions of an Alternative Urokinase Receptor and LDL Receptor-Related Protein J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2090 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Das, G. H. Mahabeleshwar, and G. C. Kundu Osteopontin Induces AP-1-mediated Secretion of Urokinase-type Plasminogen Activator through c-Src-dependent Epidermal Growth Factor Receptor Transactivation in Breast Cancer Cells J. Biol. Chem., March 19, 2004; 279(12): 11051 - 11064. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bdeir, A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A.-R. Higazi, and D. B. Cines The kringle stabilizes urokinase binding to the urokinase receptor Blood, November 15, 2003; 102(10): 3600 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Das, G. H. Mahabeleshwar, and G. C. Kundu Osteopontin Stimulates Cell Motility and Nuclear Factor {kappa}B-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells J. Biol. Chem., August 1, 2003; 278(31): 28593 - 28606. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Madison Migration of Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 8 - 11. [Full Text] [PDF] |
||||
![]() |
E. Abraham, M. R. Gyetko, K. Kuhn, J. Arcaroli, D. Strassheim, J. S. Park, S. Shetty, and S. Idell Urokinase-Type Plasminogen Activator Potentiates Lipopolysaccharide-Induced Neutrophil Activation J. Immunol., June 1, 2003; 170(11): 5644 - 5651. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Carlin, M. Roth, and J. L. Black Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1020 - L1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shetty, K. Bdeir, D. B. Cines, and S. Idell Induction of Plasminogen Activator Inhibitor-1 by Urokinase in Lung Epithelial Cells J. Biol. Chem., May 9, 2003; 278(20): 18124 - 18131. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Kim, Y.-K. Hong, Y. A. Joe, Y. Lee, J.-Y. Shin, H.-E. Park, I.-H. Lee, S.-Y. Lee, D.-K. Kang, S.-I. Chang, et al. Anti-angiogenic Activity of the Recombinant Kringle Domain of Urokinase and Its Specific Entry into Endothelial Cells J. Biol. Chem., March 21, 2003; 278(13): 11449 - 11456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Netzel-Arnett, D. J. Mitola, S. S. Yamada, K. Chrysovergis, K. Holmbeck, H. Birkedal-Hansen, and T. H. Bugge Collagen Dissolution by Keratinocytes Requires Cell Surface Plasminogen Activation and Matrix Metalloproteinase Activity J. Biol. Chem., November 15, 2002; 277(47): 45154 - 45161. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sidenius, A. Andolfo, R. Fesce, and F. Blasi Urokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor Oligomerization J. Biol. Chem., July 26, 2002; 277(31): 27982 - 27990. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sliva, M. T. Rizzo, and D. English Phosphatidylinositol 3-Kinase and NF-kappa B Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen Activator J. Biol. Chem., January 25, 2002; 277(5): 3150 - 3157. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations Am. J. Pathol., January 1, 2002; 160(1): 237 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Page, A. J. Ammit, J. L. Black, and C. L. Armour Human mast cell and airway smooth muscle cell interactions: implications for asthma Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1313 - L1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. JEFFERY Remodeling in Asthma and Chronic Obstructive Lung Disease Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S28 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. BLACK, M. ROTH, J. LEE, S. CARLIN, and P. R. A. JOHNSON Mechanisms of Airway Remodeling . Airway Smooth Muscle Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S63 - 66. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |